Periprocedural Management and Approach to Bleeding in Patients Taking Dabigatran

被引：78

作者：

Weitz, Jeffrey I. ^{[1
,2
,3
]}

Quinlan, Daniel J. ^{[4
]}

Eikelboom, John W. ^{[1
,2
]}

机构：

[1] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada

[2] McMaster Univ, Dept Med, Hamilton, ON, Canada

[3] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada

[4] Kings Coll Hosp London, Dept Radiol, London, England

来源：

CIRCULATION | 2012年 / 126卷 / 20期

基金：

加拿大健康研究院;

关键词：

PROTHROMBIN COMPLEX CONCENTRATE; ORAL DIRECT THROMBIN; REVERSAL; WARFARIN;

D O I：

10.1161/CIRCULATIONAHA.112.123224

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2428 / 2432

页数：5

共 18 条

[1]

[Anonymous], PRAD SUMM PROD CHAR

[2]

[Anonymous], PRAD PROD MON

[3] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].

COCKCROFT, DW ;

GAULT, MH .

NEPHRON, 1976, 16 (01) :31-41

[4] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[5] Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects [J].

Eerenberg, Elise S. ;

Kamphuisen, Pieter W. ;

Sijpkens, Meertien K. ;

Meijers, Joost C. ;

Buller, Harry R. ;

Levi, Marcel .

CIRCULATION, 2011, 124 (14) :1573-1579

[6] Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial [J].

Eikelboom, John W. ;

Wallentin, Lars ;

Connolly, Stuart J. ;

Ezekowitz, Mike ;

Healey, Jeff S. ;

Oldgren, Jonas ;

Yang, Sean ;

Alings, Marco ;

Kaatz, Scott ;

Hohnloser, Stefan H. ;

Diener, Hans-Christoph ;

Franzosi, Maria Grazia ;

Huber, Kurt ;

Reilly, Paul ;

Varrone, Jeanne ;

Yusuf, Salim .

CIRCULATION, 2011, 123 (21) :2363-U72

[7] Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development [J].

Eriksson, Bengt I. ;

Quinla, Datfiel J. ;

Weitz, Jeffrey I. .

CLINICAL PHARMACOKINETICS, 2009, 48 (01) :1-22

[8] Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays [J].

Lindahl, Tomas L. ;

Baghaei, Fariba ;

Blixter, Inger Fagerberg ;

Gustafsson, Kerstin M. ;

Stigendal, Lennart ;

Sten-Linder, Margareta ;

Strandberg, Karin ;

Hillarp, Andreas .

THROMBOSIS AND HAEMOSTASIS, 2011, 105 (02) :371-378

[9] Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model [J].

Pragst, I. ;

Zeitler, S. H. ;

Doerr, B. ;

Kaspereit, F. J. ;

Herzog, E. ;

Dickneite, G. ;

Van Ryn, J. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (09) :1841-1848

[10] Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran [J].

Stangier, Joachim ;

Feuring, Martin .

BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (02) :138-143

← 1 2 →